Holdco Nuvo Group DG Ltd (NUVO) News

Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company’s Commitment to Transforming Prenatal Care

TEL AVIV, Israel, May 09, 2024 (GLOBE NEWSWIRE) -- Holdco Nuvo Group D.G Ltd (NASDAQ: NUVO) (“Nuvo”), a...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

- Current report filing (8-K)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

Filed by Nuvelo, Inc. Pursuant to Rule 425 Under the Securities Act of 1933 And Deemed Filed Pursuant to Rule 14a-12 Under the...

- Current report filing (8-K)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

Filed by Nuvelo, Inc. Pursuant to Rule 425 Under the Securities Act of 1933 And Deemed Filed Pursuant to Rule 14a-12 Under the Securities...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A (RULE...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

Filed by Nuvelo, Inc. Pursuant to Rule 425 Under the Securities Act of 1933 And Deemed Filed Pursuant to...

ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference

Webcast Presentation Scheduled for Wednesday, January 14, 2009 at 9:30 a.m. PT BROOMFIELD, Colo. and SAN CARLOS, Calif., Jan. 8...

- Filing of certain prospectuses and communications in connection with business combination transactions (425)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT...